Acadian Asset Management LLC / JAZZ
Acadian Asset Management LLC’s Jazz Pharmaceuticals PLC Position
Does Acadian Asset Management LLC own Jazz Pharmaceuticals PLC (JAZZ)? Yes — 54.8K shares worth $10M (+0.01% of its 13F portfolio) as of Q1 2026, up from 1.7K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
54.8K
% of Portfolio
+0.01%
Quarters Held
13
currently held
Position History JAZZ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 54.8K | $10M | +0.01% |
| Q4 2025 | 1.7K | $286,000 | 0.00% |
| Q1 2025 | 730 | $90,000 | 0.00% |
| Q2 2021 | 100.0K | $18M | +0.07% |
| Q1 2021 | 178.1K | $29M | +0.11% |
| Q4 2020 | 238.6K | $39M | +0.15% |
| Q3 2020 | 367.8K | $52M | +0.22% |
| Q2 2020 | 461.5K | $51M | +0.22% |
| Q1 2020 | 427.8K | $43M | +0.24% |
| Q4 2019 | 466.3K | $70M | +0.32% |
| Q3 2019 | 522.3K | $67M | +0.29% |
| Q2 2019 | 482.7K | $69M | +0.33% |
| Q1 2019 | 448.8K | $64M | +0.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of JAZZ.